Press Release
Ondas Announces Intent to Invest up to $11 Million in Drone Fight Group to Accelerate Access to Advanced Ukrainian Drone Technology
First strategic investment by Ondas Capital intended to strengthen U.S. and allied defense modernization priorities with combat-proven Ukrainian technologies Ondas Capital plans to support localization via U.S.-based, NDAA-compliant manufacturing and integrated customer support, training and sustainment Read More
Press Release
Stateline Project - Metallurgical collaboration and Targeting Work Advancing
HIGHLIGHTS More than 60 historic drillholes digitised to date record >3,000 ppm U₃O₈, confirming the district's strong uranium-vanadium signature. Mapping of a 700 ppm U₃O₈ cut-off envelope underway, defining multiple coherent mineralised trends. A distinct northwest target zone (Dakota/Burro Canyon) identified, with historic assays up to 0.45% U₃O₈ and 3.45% V₂O₅. UAR enters a collaboration with DISA Technologies to undertake bench-scale metallurgical test work and site surveys at no cost to UAR. Read More
Press Release
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy's cash price Proprietary EinsteinRx™ artificial intelligence pharmacy platform empowers the 6,500+ pharmacies in the Wellgistics Pharmacy Network to educate patients and providers on the advantages of Brenzavvy vs. Jardiance® and other SGLT-2 inhibitors Reduced out-of-pocket costs for patients, paired with a patient-education revenue opportunity for pharmacists, are designed to support broader market access to Brenzavvy and enhance the overall care experience Launch establishes a new model for next-generation reformulated drugs that offer patient-specific product advantages compared with entrenched market leaders Read More
Press Release
Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have access to controlled substances for legitimate medical use. Today, the evidence shows the opposite: DEA officials laundering cartel money, DEA lawyers defending unconstitutional judicial processes, DEA executives cycling into industry roles they once regulated and DEA policies obstructing legitimate FDA authorized medical research. Read More
Press Release
Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. Read More
Press Release
Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI PUBLIER, DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, EN TOTALITÉ OU EN PARTIE, AUX ÉTATS-UNIS OU À DESTINATION DES ÉTATS-UNIS. Read More
Press Release
